Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

休市中 01-09 16:00:00 EST

34.30

+0.44

+1.30%

盘后34.35

+0.05+0.15%

19:59 EST

最高35.41	最低33.94	成交量755.13万
今开34.30	昨收33.86	日振幅4.34%
总市值134.00亿	流通市值124.61亿	总股本3.91亿
成交额2.61亿	换手率2.08%	流通股本3.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":34.3,"timestamp":1767992400000,"preClose":33.86,"halted":0,"volume":7551321,"hourTrading":{"tag":"盘后","latestPrice":34.35,"preClose":34.3,"latestTime":"19:59 EST","volume":139697,"amount":4791294.0987,"timestamp":1768006771334},"delay":0,"floatShares":363290461,"shares":390679512,"eps":-8.051605,"marketStatus":"休市中","change":0.44,"latestTime":"01-09 16:00:00 EST","open":34.298,"high":35.4098,"low":33.94,"amount":260674545.93519,"amplitude":0.043408,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.051605,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":33.86,"preHourTrading":{"tag":"盘前","latestPrice":34.34,"preClose":33.86,"latestTime":"09:29 EST","volume":18717,"amount":639290.608521,"timestamp":1767968999990},"postHourTrading":{"tag":"盘后","latestPrice":34.35,"preClose":34.3,"latestTime":"19:59 EST","volume":139697,"amount":4791294.0987,"timestamp":1768006771334},"volumeRatio":0.5956448995730913,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1768539600000,"strike":"37.0","timestamp":1767971947705,"price":0.71,"volume":7780,"amount":552380,"type":"-"},{"symbol":"MRNA","call":true,"expireDate":1767934800000,"strike":"31.5","timestamp":1767970319819,"price":2.7,"volume":4990,"amount":1347300,"type":"+"}]},"impliedVol":0.6455,"impliedVolPercentile":0.0837},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"1146876963","title":"异动解读 | 拜耳起诉专利侵权，Moderna盘中大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146876963","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146876963?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:42","pubTimestamp":1767897738,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘中大跌5.02%，引发市场关注。消息面上，拜耳公司已对Moderna提起诉讼，指控其侵犯了与mRNA技术相关的知识产权。拜耳声称，Moderna在开发新冠疫苗时使用了拜耳十年前收购的孟山都公司开发的技术，以提高mRNA的稳定性和蛋白质产量。拜耳要求获得疫苗销售收入的一部分以及未来销售的特许权使用费。此次诉讼增加了Moderna面临的法律和财务不确定性，可能导致投资者担忧，从而引发股价下跌。此前，Moderna已卷入多起类似诉讼，包括与GSK和辉瑞/BioNTech的纠纷。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"2601332259","title":"瑞银：首次覆盖Moderna给予中性评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601332259","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601332259?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:16","pubTimestamp":1767777369,"startTime":"0","endTime":"0","summary":"格隆汇1月7日｜瑞银：首次覆盖Moderna(MRNA.US)，给予中性评级，目标价定为34美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107171640a4a71757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107171640a4a71757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4501","BK4139","BK4588","BK4532","BK4548","BK4568","BK4533","BK4585","MRNA","BK4551","BK4534"],"gpt_icon":0},{"id":"1155761991","title":"异动解读 | Moderna盘中大涨10.97%，因BofA上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155761991","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155761991?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:56","pubTimestamp":1767714986,"startTime":"0","endTime":"0","summary":"Moderna（MRNA）今日盘中大涨10.97%，成为市场焦点。消息面上，BofA全球研究公司上调了Moderna的目标股价，这一举措显著提升了投资者对该股的信心，推动其股价大幅上涨。医疗保健板块整体表现强劲，进一步带动了Moderna的涨势。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"65ea9bea0b0ef90fd686d76394fa8759","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1127867080","title":"美股生物医药股集体上扬！Moderna涨超7%，Sarepta Therapeutics涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127867080","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127867080?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:04","pubTimestamp":1767711863,"startTime":"0","endTime":"0","summary":"1月6日，美股生物医药股集体上扬，$Moderna(MRNA)$涨超7%，$Sarepta Therapeutics(SRPT)$涨超6%，$诺和诺德(NVO)$、$诺瓦瓦克斯医药(NVAX)$涨超5%，$葛兰素史克(GSK)$涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"65ea9bea0b0ef90fd686d76394fa8759","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","SRPT","IE0009355771.USD","BK4007","MRNA","IE0002141913.USD","BK4539","BK4139","IE00BFTCPJ56.SGD","NVO","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"1189722170","title":"异动解读 | Moderna流感疫苗提交多国上市申请，盘中大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189722170","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189722170?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:46","pubTimestamp":1767624383,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中股价大涨5.02%，引发市场关注。消息面上，Moderna宣布已向美国FDA、欧洲EMA、加拿大卫生部及澳大利亚TGA同步提交其mRNA流感疫苗mRNA-1010的上市授权申请。这一关键进展标志着该疫苗在全球主要市场的监管审批正式启动，若获批将成为公司继新冠疫苗后的又一重磅产品，为季节性流感预防提供创新解决方案。此外，Moderna近期还公布了2025年16亿至20亿美元的营收目标，并强化商业团队建设以推动季节性疫苗业务发展，进一步巩固了投资者对公司长期增长潜力的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1163124127","title":"Moderna公司：商业团队夯实季节性疫苗业务基础，瞄准2025年16至20亿美元营收目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1163124127","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163124127?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:19","pubTimestamp":1767622757,"startTime":"0","endTime":"0","summary":"Moderna公司正通过强化商业团队建设，为其季节性疫苗业务奠定坚实基础。公司最新规划显示，其目标是在2025年实现16亿至20亿美元的营收预期区间。\n这一战略部署凸显了该生物技术巨头对疫苗商业化进程的加速推进。随着全球公共卫生体系对呼吸道疫苗需求的持续增长，Moderna正通过优化销售网络、提升市场渗透率等措施，不断增强其在季节性疫苗领域的竞争壁垒。\n值得注意的是，此次公布的营收指引较以往更为具体，反映出公司对核心业务增长轨迹的清晰预判。通过将商业团队建设与产品管线发展相结合，Moderna正在构建一个更具韧性的疫苗生态系统。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4501","BK4551","BK4548","BK4588","BK4534","BK4568","BK4585","BK4532","BK4139","BK4533"],"gpt_icon":0},{"id":"1187386977","title":"Moderna, Inc. 目标营收区间锁定16至20亿美元，商业团队夯实季节性疫苗业务基础","url":"https://stock-news.laohu8.com/highlight/detail?id=1187386977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187386977?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:11","pubTimestamp":1767622263,"startTime":"0","endTime":"0","summary":"随着其商业团队成功巩固了季节性疫苗产品线的市场基础，Moderna, Inc. 已将未来的营收目标设定在16亿至20亿美元的预期区间内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4532","BK4139","BK4548","MRNA","BK4551","BK4588","BK4585","BK4568","BK4501","BK4533"],"gpt_icon":0},{"id":"1105519242","title":"Moderna向多国监管机构提交流感疫苗mRNA-1010上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1105519242","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105519242?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:13","pubTimestamp":1767615196,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna宣布，其研发的mRNA流感疫苗mRNA-1010已正式向美国食品药品监督管理局（FDA）、欧洲药品管理局（EMA）、加拿大卫生部（Health Canada）以及澳大利亚治疗商品管理局（TGA）提交上市授权申请。这一关键进展标志着该疫苗在全球主要市场的监管审批程序全面启动。\n此次多国同步申报的策略凸显了Moderna对拓展呼吸道疫苗市场的战略布局。若获批，mRNA-1010将成为该公司继新冠疫苗后又一重要商业化产品，有望为季节性流感预防提供创新解决方案。业界密切关注该疫苗在审批过程中的数据表现，其技术路径与传统灭活疫苗的差异化优势或成为监管考量的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","MRNA","BK4532","BK4585","BK4501","BK4534","BK4548","BK4139","BK4588","BK4533","BK4568"],"gpt_icon":0},{"id":"1135170278","title":"异动解读 | Moderna盘中大涨5%，获资金支持与疫苗进展提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1135170278","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135170278?lang=zh_cn&edition=full","pubTime":"2025-12-23 01:00","pubTimestamp":1766422847,"startTime":"0","endTime":"0","summary":"Moderna（MRNA）今日盘中大涨5%，延续了近期强劲的上涨势头。消息面上，Moderna近期从全球联盟获得5430万美元资金，用于支持其实验性禽流感疫苗的后期开发。此外，公司于11月20日宣布从Ares Management Credit Funds获得15亿美元的五年期定期贷款融资，并设定了明年10%的收入增长目标。这些资金注入和增长预期增强了投资者信心。另据报导，美国食品药品管理局（FDA）高级官员表示，暂无计划在新冠疫苗上添加\"黑框\"警告，消除了部分监管风险。尽管近期股价上涨缺乏明确的新催化剂，但市场对Moderna的疫苗管线进展和财务健康状况持续看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8ea853fe19d6ed79624712550d8758af","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1151418720","title":"一周美股牛榜 | SanDisk、Moderna单周涨15%；嘉年华邮轮涨超12%；美光涨逾10%；AppLovin涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151418720","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151418720?lang=zh_cn&edition=full","pubTime":"2025-12-22 11:05","pubTimestamp":1766372700,"startTime":"0","endTime":"0","summary":"自2月13日以每股36美元上市以来，闪迪股价已累计上涨约560%，最新报237.61美元。该疫苗mRNA-1018有望成为首个进入关键性临床试验阶段的mRNA技术禽流感疫苗。受该消息刺激，莫德纳股价当周接近上涨15%。AppLovin股价当周上涨7.6%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8ea853fe19d6ed79624712550d8758af","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MU","SNDK","CCL","MRNA","APP"],"gpt_icon":0},{"id":"1132496363","title":"Moderna：疫情防备创新联盟将向公司的mRNA流感疫苗候选者投资高达5430万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132496363","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132496363?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:00","pubTimestamp":1766059227,"startTime":"0","endTime":"0","summary":"Moderna：疫情防备创新联盟将向公司的mRNA流感疫苗候选者投资高达5430万美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4548","BK4139","BK4585","BK4588","BK4501","BK4533","BK4551","BK4532","BK4534","MRNA"],"gpt_icon":0},{"id":"1164021921","title":"EMA的CHMP：建议批准Mnexspike的市场授权，用于12岁及以上人群的COVID-19预防","url":"https://stock-news.laohu8.com/highlight/detail?id=1164021921","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164021921?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:36","pubTimestamp":1765546591,"startTime":"0","endTime":"0","summary":"EMA的CHMP：建议批准Mnexspike的市场授权，用于12岁及以上人群的COVID-19预防","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4532","BK4501","BK4548","BK4588","MRNA","BK4585","BK4551","BK4534","BK4139","BK4533"],"gpt_icon":0},{"id":"1190207040","title":"Nanexa Ab - 将获得300万美元的预付款，并有机会获得高达5亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1190207040","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190207040?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:36","pubTimestamp":1765402573,"startTime":"0","endTime":"0","summary":"Nanexa Ab - 将获得300万美元的预付款，并有机会获得高达5亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4568","BK4533","BK4585","BK4139","BK4501","BK4588","MRNA","BK4534","BK4548","BK4532"],"gpt_icon":0},{"id":"1174468371","title":"Moderna高管表示公司尚未看到与FDA声称COVID疫苗与儿童死亡有关的数据或分析 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1174468371","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174468371?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:36","pubTimestamp":1764693376,"startTime":"0","endTime":"0","summary":"Moderna高管表示公司尚未看到与FDA声称COVID疫苗与儿童死亡有关的数据或分析 - 电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4568","BK4532","BK4139","BK4501","MRNA","BK4551","BK4534","BK4533","BK4548"],"gpt_icon":0},{"id":"1186165748","title":"美股疫苗股大跌，FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1186165748","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186165748?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:25","pubTimestamp":1764635137,"startTime":"0","endTime":"0","summary":"在疫情期间，Prasad 因反对疫苗强制措施以及对新冠疫苗引发心肌炎风险的关注而在网上获得追随者。其他研究则发现，新冠感染导致心肌炎的风险高于接种疫苗。辉瑞和 BioNTech 共同研发了新冠疫苗 Comirnaty。两家公司均研发并销售新冠 mRNA 疫苗。这并非 Prasad 首次推动与 mRNA 新冠疫苗相关的变更。这位 FDA 官员还呼吁为疫苗临床试验设定不同的终点指标。","market":"us","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"美股疫苗股大跌，FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","MRNA","DVAX","BNTX"],"gpt_icon":1},{"id":"1199033044","title":"美股异动 | 疫苗股下跌，Moderna跌超6%！FDA提及儿童死亡与新冠疫苗关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1199033044","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199033044?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:26","pubTimestamp":1764602786,"startTime":"0","endTime":"0","summary":"12月1日，部分美股疫苗股盘中下跌，$Moderna(MRNA)$跌超6%，$诺瓦瓦克斯(NVAX)$跌近4%，$BioNTech(BNTX)$跌超3%。此前$美国食品(USFD)$药物管理局备忘录提及儿童死亡与新冠疫苗的关联。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","MRNA","BNTX"],"gpt_icon":0},{"id":"1116171517","title":"异动解读 | FDA备忘录将儿童死亡与疫苗关联，Moderna盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116171517","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116171517?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:16","pubTimestamp":1764602191,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中大跌5%，引发市场关注。消息面上，美国食品药品监督管理局（FDA）首席医疗和科学官维奈-普拉萨德（Vinay Prasad）在一份备忘录中表示，新冠疫苗接种可能导致至少10名儿童死于心脏炎症。这一发现引发了市场对疫苗安全性的担忧，并可能导致更严格的监管审查。该备忘录基于对2021年至2024年期间96例死亡病例的初步分析，但未透露所涉及的疫苗生产商或儿童的具体健康状况。普拉萨德称这一发现为“深刻的启示”，并宣布了加强疫苗监管的计划。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1171006404","title":"异动解读 | FDA备忘录关联儿童死亡，Moderna盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171006404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171006404?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:16","pubTimestamp":1764602180,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘中大跌5%，引发市场关注。消息面上，美国食品和药物管理局（FDA）首席医疗和科学官维奈-普拉萨德在一份备忘录中表示，新冠疫苗接种可能导致至少10名儿童死于心脏炎症。这一发现被描述为“深刻的启示”，并促使FDA宣布加强疫苗监管的计划。尽管备忘录未明确提及涉及的疫苗生产商，但市场普遍认为这一消息对Moderna等疫苗制造商的股价产生了负面影响。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"2585319384","title":"接种率越来越低，昔日“明星疫苗股”Moderna成为最被做空的美股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585319384","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585319384?lang=zh_cn&edition=full","pubTime":"2025-11-24 12:10","pubTimestamp":1763957440,"startTime":"0","endTime":"0","summary":"卖空数据公司S3 Partners统计，自9月底以来Moderna一直是标普500指数中被做空最多的股票，2025年卖空者在该公司股票上获得约6.22亿美元的未实现收益。在美国卫生部长Robert F Kennedy Jr数月来的反疫苗言论影响下，市场对疫苗的需求急剧萎缩。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759965","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759965","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"gpt_icon":0},{"id":"1100499484","title":"异动解读 | 摩德纳获15亿美元贷款后股价仍大跌5%，投资者对增长前景存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=1100499484","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100499484?lang=zh_cn&edition=full","pubTime":"2025-11-21 02:42","pubTimestamp":1763664147,"startTime":"0","endTime":"0","summary":"生物科技公司摩德纳周四盘中大跌5%，尽管公司宣布获得15亿美元贷款并提出未来增长计划，但投资者似乎对其前景仍持谨慎态度。摩德纳表示已从Ares Management获得一笔15亿美元、为期五年的贷款。摩德纳总裁Stephen Hoge表示，这笔贷款将为公司提供灵活性，用以资助业务拓展或管理风险。然而，摩德纳自疫情带来的巨额收益消退后一直面临财务压力。摩德纳预计2025年销售额仅为16亿至20亿美元，2026年收入增长目标为10%左右。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e9dfbd4d9d200c480e5ae33594ae92e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":0.1115},{"period":"1month","weight":0.1815},{"period":"3month","weight":0.2784},{"period":"6month","weight":0.0196},{"period":"1year","weight":-0.2055},{"period":"ytd","weight":0.1631}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.070914},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.012362},{"month":3,"riseRate":0.571429,"avgChangeRate":0.028598},{"month":4,"riseRate":0.714286,"avgChangeRate":0.123955},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106584},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}